(Q53962194)

title

Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape. (English)

1 reference

23 May 2018

evasion of host immune response

main subject

pancreas

0 references

1 reference

4

1 reference

23 May 2018

Robert D Odze

3

object named as

Robert D Odze

1 reference

23 May 2018

author name string

Wolfram V Bernstorff

1

1 reference

23 May 2018

Jonathan N Glickman

2

1 reference

23 May 2018

Hong G Joo

5

1 reference

23 May 2018

Peter S Goedegebuure

6

1 reference

23 May 2018

Timothy J Eberlein

7

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 May 2002

1 reference

23 May 2018

1 reference

23 May 2018

volume

94

1 reference

23 May 2018

page(s)

2552-2560

1 reference

23 May 2018

issue

10

1 reference

23 May 2018

Apoptosis by death factor

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Fas ligand mediates activation-induced cell death in human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

The role of FasL-induced apoptosis in immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Human pancreatic cancer cells (MPanc-96) recognized by autologous tumor-infiltrating lymphocytes after in vitro as well as in vivo tumor expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

The Fas counterattack: cancer as a site of immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

CD95 antigen mutations in hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Somatic mutations in the death domain of the Fas (Apo-1/CD95) gene in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

7 January 2021

Resistance to apoptosis correlates with a highly proliferative phenotype and loss of Fas and CPP32 (caspase-3) expression in human leukemia cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

7 January 2021

Expression of Fas antigen in acute myeloid leukaemia is associated with therapeutic response to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

7 January 2021

Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

7 January 2021

The current contribution of molecular factors to risk estimation in neuroblastoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

7 January 2021

Differential and mutually exclusive expression of CD95 and CD95 ligand in epithelia of normal pancreas and chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

7 January 2021

Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

7 January 2021

CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BALB/c mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

7 January 2021

Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10549

7 January 2021

Identifiers

1 reference

23 May 2018

1 reference

23 May 2018